For Health Systems and Insurers
The Enigma consumer platform depends on institutional partnerships. If you operate a health system, manage an insurer's data infrastructure, or run clinical research operations, we should talk.
What We Offer Institutions
Quantum-Safe Data Custody
Migrate your genomic archives to post-quantum encryption before harvest-now-decrypt-later attacks make your current protection obsolete. Built on NIST-finalized FIPS 203/204/205 standards.
Consent-Enforced Data Access
Every query against patient data is evaluated against current consent state in real time. Revocations propagate in under 60 seconds. Audit trails satisfy 21 CFR Part 11.
Cross-Institutional Identity Resolution
Enigma Biological ID (EBID) resolves patient identity across institutions without exposing demographics. Eliminates duplicate records, reduces re-screening costs, enables longitudinal research.
Who We Work With
Health Systems
Hospitals, academic medical centers, and integrated delivery networks managing genomic data at scale.
Insurers
Payers seeking to align coverage incentives with early detection and prevention.
Clinical Research Organizations
Re-screening rates in rare disease trials run 20-80%. Every failed re-screen costs $1,170-$3,240 per patient.
Enigma eliminates this cost permanently. Once a participant enrolls with an EBID, their verified status is reusable across every future trial — compressing enrollment timelines from 8-20 weeks to 1-3 weeks and cutting re-screening budgets by 60-80%.
Biobanks
Population genomics programs requiring longitudinal identity and consent enforcement.
Looking for Technical Details?
Our enterprise documentation includes full technical specifications, deployment architecture, compliance documentation, and ROI models for institutional buyers.
Contact us to receive access to the institutional portal with CISO-ready materials, pilot program details, and technical integration guides.